​

Madrigal Pharmaceuticals (MDGL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Madrigal Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$180.13M

Latest Revenue (Q)

$212.80M

Madrigal Pharmaceuticals Revenue by Period

Madrigal Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$180.13M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--100.00%
2012-12-31$147.00K-98.06%
2011-12-31$7.58M-48.77%
2010-12-31$14.80M-89.74%
2009-12-31$144.25M5416.06%
2008-12-31$2.62M251.95%
2007-12-31$743.00K100.00%
2006-12-31-100.00%
2005-12-31--100.00%
2004-12-31$173.00K-86.73%
2003-12-31$1.30M100.00%
2002-12-31-100.00%
2001-12-31--

Madrigal Pharmaceuticals generated $180.13M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Madrigal Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-06-30$212.80M55.05%
2025-03-31$137.25M32.84%
2024-12-31$103.32M66.18%
2024-09-30$62.17M324.75%
2024-06-30$14.64M100.00%
2024-03-31--100.00%
2023-12-31$770.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30--100.00%
2012-03-31$147.00K-95.71%
2011-12-31$3.42M105.71%
2011-09-30$1.66M22.90%
2011-06-30$1.35M18.46%
2011-03-31$1.14M-71.69%
2010-12-31$4.04M19.33%
2010-09-30$3.38M0.68%
2010-06-30$3.36M-16.48%
2010-03-31$4.02M-14.04%
2009-12-31$4.68M-96.41%
2009-09-30$130.41M2704.41%
2009-06-30$4.65M3.10%
2009-03-31$4.51M609.12%
2008-12-31$636.00K-50.00%
2008-09-30$1.27M-4.93%
2008-06-30$1.34M-
2008-03-31$1.34M100.00%
2007-12-31--

Madrigal Pharmaceuticals generated $212.80M in revenue during Q2 2025, up 55.05% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Madrigal Pharmaceuticals Revenue Breakdown

Madrigal Pharmaceuticals Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceJun 25
Reportable Segment$212.80M

Madrigal Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Reportable Segment (100.00%).

Madrigal Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
JAZZJazz Pharmaceuticals$4.07B$1.05B
MRNAModerna$3.24B$143.00M
BMRNBioMarin Pharmaceutical$2.85B$825.41M
EXELExelixis$2.17B$568.26M
TECHBio-Techne$1.16B$297.03M
IONSIonis Pharmaceuticals$705.14M$452.00M
BBIOBridgeBio Pharma$221.90M$71.50M
MDGLMadrigal Pharmaceuticals$180.13M$212.80M
ROIVRoivant Sciences$124.80M$7.57M
VRNAVerona Pharma$42.28M$76.26M
RVMDRevolution Medicines--

MDGL Revenue FAQ

What is Madrigal Pharmaceuticals’s yearly revenue?

Madrigal Pharmaceuticals's yearly revenue for 2024 was $180.13M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. MDGL's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Madrigal Pharmaceuticals’s quarterly revenue?

Madrigal Pharmaceuticals's quarterly revenue for Q2 2025 was $212.8M, a 55.05% increase from the previous quarter (Q1 2025), and a 1353.76% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $137.25M, a 32.84% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). MDGL's quarterly revenue for Q4 2024 was $103.32M, a 66.18% increase from the previous quarter (Q3 2024), and a 13318.18% increase year-over-year (Q4 2023).

What is Madrigal Pharmaceuticals’s revenue growth rate?

Madrigal Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.